SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium Ansu O

Total Page:16

File Type:pdf, Size:1020Kb

SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium Ansu O Published OnlineFirst July 9, 2018; DOI: 10.1158/0008-5472.CAN-18-0043 Cancer Molecular Cell Biology Research SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium Ansu O. Perekatt1,2, Pooja P. Shah1, Shannon Cheung1, Nidhi Jariwala2,3, Alex Wu1, Vishal Gandhi1, Namit Kumar1, Qiang Feng4, Neeket Patel1, Lei Chen1, Shilpy Joshi2, Anbo Zhou1, M. Mark Taketo5, Jinchuan Xing1, Eileen White2, Nan Gao2,4, Michael L. Gatza1,2,3, and Michael P. Verzi1,2 Abstract The cell of origin of colon cancer is typically thought to be the WNT pathway led to dedifferentiation and rapid adenoma the resident somatic stem cells, which are immortal and escape formation in differentiated tissue. Transcriptional profiling the continual cellular turnover characteristic of the intestinal revealed acquisition of stem cell characteristics, and colabeling epithelium. However, recent studies have identified certain indicated that cells expressing differentiated enterocyte conditions in which differentiated cells can acquire stem-like markers entered the cell cycle and reexpressed stem cell properties and give rise to tumors. Defining the origins of genes upon simultaneous loss of SMAD4 and activation of tumors will inform cancer prevention efforts as well as cancer the WNT pathway. These results indicate that SMAD4 therapies, as cancers with distinct origins often respond dif- functions to maintain differentiated enterocytes in the ferently to treatments. We report here a new condition in presence of oncogenic WNT signaling, thus preventing which tumors arise from the differentiated intestinal epithe- dedifferentiation and tumor formation in the differentiated lium. Inactivation of the differentiation-promoting transcrip- intestinal epithelium. tion factor SMAD4 in the intestinal epithelium was surpris- ingly well tolerated in the short term. However, after several Significance: This work identifies a mechanism through months, adenomas developed with characteristics of activated which differentiated cells prevent tumor formation by suppres- WNT signaling. Simultaneous loss of SMAD4 and activation of sing oncogenic plasticity. Cancer Res; 78(17); 4878–90. Ó2018 AACR. Introduction cancer—a model elegantly supported by in vivo mouse studies (1). However, histologic evidence from human patients with colon The intestinal epithelium is strictly compartmentalized—with cancer supports the notion that dysplastic cells arise from differ- stem and proliferative cells nestled into the intestinal wall in the entiated cells (2). Such a scenario requires the differentiated cells crypts of Lieberkuhn€ and differentiated cells lining the lumen on to acquire stem-like properties for oncogenesis (3, 4). The tumor villi in the small intestine or mucosal surface in the colon. Cells cell of origin often dictates the epigenetic status of the tumor and continuously transit from the crypt to the mucosal surface, where can influence treatment strategies (5, 6). they are shed into the lumen. Stem cells and their niche-support- Recent studies have shown that combinations of genetic altera- ing Paneth cells are the only cell types that remain anchored to the tions can trigger stem cell activity from differentiated intestinal crypt base and escape this cellular transit. This pattern of move- epithelial cells in mice. These include simultaneous mutations in ment prevents accumulation of oncogenic mutations in differen- APC and KRAS as well as simultaneous activation of the WNT and tiated cells, as differentiated cells will be lost into the lumen. NF-kB pathways (7, 8). The potential for plasticity in normal Hence, stem cells are thought to be the cell of origin of colon differentiated intestinal epithelial cells is also supported by experiments showing that upon loss of endogenous crypt base þ columnar (Lgr5 ) stem cells, the progenitor cell populations of 1Department of Genetics, Human Genetics Institute of New Jersey, Rutgers, The distinct intestinal lineages can dedifferentiate and acquire the fate þ State University of New Jersey, Piscataway, New Jersey. 2Rutgers Cancer of Lgr5 cells, which are the actively cycling stem cells of the Institute of New Jersey, New Brunswick, New Jersey. 3Department of Radiation intestine (9). These studies have shown that cells previously Oncology, Robert Wood Johnson Medical School, New Brunswick, New Jersey. referred to as "reserve" or "þ4" cell populations include enter- 4Department of Biological Sciences, Rutgers University, Newark, New Jersey, 5 oendocrine progenitor cells that can dedifferentiate into active New Jersey. Division of Experimental Therapeutics, Graduate School of Med- – þ icine, Kyoto University, Sakyo Kyoto, Japan. stem cells (10 13). In these dedifferentiation models, Lgr5 stem cells are typically replaced by neighboring progenitor cells in the Note: Supplementary data for this article are available at Cancer Research crypt, rather than cells luminally positioned on the more differ- Online (http://cancerres.aacrjournals.org/). entiated villus. Corresponding Author: MichaelP.Verzi,Rutgers,TheStateUniversityofNew SMAD4 is a transcriptional effector of the BMP- and TGFb- Jersey,Piscataway,NJ08854.Phone:848-445-9578; E-mail: [email protected] signaling pathways. The Cancer Genome Atlas (TCGA) research doi: 10.1158/0008-5472.CAN-18-0043 network has identified mutations in SMAD4 to be among the Ó2018 American Association for Cancer Research. most frequently mutated genes in colon cancers (14), and loss of 4878 Cancer Res; 78(17) September 1, 2018 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2018 American Association for Cancer Research. Published OnlineFirst July 9, 2018; DOI: 10.1158/0008-5472.CAN-18-0043 SMAD4 Suppresses WNT-Driven Dedifferentiation in the Gut þ Smad4 heterozygosity in the Apcmin/ mouse colon tumor back- Microscopy and imaging ground promotes invasive progression of colon adenomas (15). Nikon Eclipse E800 microscope and Retiga 1300CCD BMP signaling is required to maintain the differentiated state (Q-Imaging) cameras were used for bright field microscopy. For in the intestinal epithelium (16–18), as expression of BMP fluorescent microscopy, Zeiss Axiovert 200M microscope and inhibitors beginning at embryonic stages leads to emergence of Retiga-SRV CCD (Q-Imaging) QC imaging were used for crypt-like structures in the villi of the adult tissue. However, image acquisition. Keynote, the apple software, was used for the mechanisms and subsequent events leading to the loss of adjustments of sharpness and contrast and applied equally for differentiation in the intestinal epithelium are incompletely comparative images. ImageJ software was used for merging fluo- understood, particularly whether adult-onset disruption of BMP rescent images. signaling would lead to tumorigenesis from differentiated tissues. The following study expands our understanding of differenti- Villi and crypt cultures ated-cell-derived tumorigenesis by demonstrating that simulta- Villi from the proximal half of the duodenum were isolated in neous loss of SMAD4 and activation of the WNT pathway triggers the following manner with extreme care to avoid contamination stem cell properties and adenoma formation in the differentiated from crypts. Mice of the indicated genotypes were treated with epithelium of the adult intestine. tamoxifen for 4 consecutive days. The proximal half of the duodenum was harvested on day 10 after the first tamoxifen injection, flushed with cold PBS, opened longitudinally and laid Materials and Methods on clean 100 mm petri plate with villi facing up. Two histologic Mouse models glass slides were used to isolate the villi by scraping: one to hold fl fl The Villin-CreERT2 transgene (19), Smad4 ox/ ox (20), and Catn- down the intestine, and the other to scrape. Only two villi-yielding þ blox(ex3)/ (21) alleles were integrated to generate the conditional scrapes were carried out (to avoid crypts). The villi collected were compound mutants and controls. The Lgr5-EGFP-ires-CreERT2 washed with PBS and isolated from smaller debris using a 70-mm allele (22) was used for mosaic Cre induction. Tamoxifen was filter with cold PBS to wash the villi and filter out any crypts if administered at 0.05 g/kg mice, intraperitoneally, for 4 consecu- present. Fifty villi in 25 mL of Matrigel (Corning, 356230) were tive days to induce Cre recombination. All the experiments con- plated per well in a 48-well plate. The villi were cultured in ENR ducted had the approval of the Rutgers Institutional Animal Care media (23) with 2 mg/mL primocin. Crypts were isolated and Use Committee. from proximal duodenum and cultured in BME-R1 Matrigel (Trevigen, Cat#3433-005-R1) according to previously described Histology and immunohistochemistry methods (23). Intestines were fixed with 4% paraformaldehyde overnight at 4 C and washed in PBS prior to dehydration and paraffin RNA isolation and analysis embedding. Mice were injected with 100 mg of EdU (Thermo RNA was extracted from jejunal epithelia of the indicated Fisher Scientific, cat #C10337) 1 hour prior to sacrificing when genotypes in triplicates following 4 consecutive days of tamoxifen the tissues were prepared for EdU labeling of proliferating cells. injection. Uninjected mice served as control. After flushing the Five-micron sections were prepared from paraffin for histologic freshly harvested jejunum with cold PBS, the epithelia were analysis. For immunostaining, antigen retrieval was performed dissociated from underlying mesenchyme by incubating with with 10 mmol/L
Recommended publications
  • The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models
    biomolecules Review The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models Meera Krishnan 1, Sahil Kumar 1, Luis Johnson Kangale 2,3 , Eric Ghigo 3,4 and Prasad Abnave 1,* 1 Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Ex-pressway, Faridabad 121001, India; [email protected] (M.K.); [email protected] (S.K.) 2 IRD, AP-HM, SSA, VITROME, Aix-Marseille University, 13385 Marseille, France; [email protected] 3 Institut Hospitalo Universitaire Méditerranée Infection, 13385 Marseille, France; [email protected] 4 TechnoJouvence, 13385 Marseille, France * Correspondence: [email protected] Abstract: Adult stem cells (ASCs) are the undifferentiated cells that possess self-renewal and differ- entiation abilities. They are present in all major organ systems of the body and are uniquely reserved there during development for tissue maintenance during homeostasis, injury, and infection. They do so by promptly modulating the dynamics of proliferation, differentiation, survival, and migration. Any imbalance in these processes may result in regeneration failure or developing cancer. Hence, the dynamics of these various behaviors of ASCs need to always be precisely controlled. Several genetic and epigenetic factors have been demonstrated to be involved in tightly regulating the proliferation, differentiation, and self-renewal of ASCs. Understanding these mechanisms is of great importance, given the role of stem cells in regenerative medicine. Investigations on various animal models have played a significant part in enriching our knowledge and giving In Vivo in-sight into such ASCs regulatory mechanisms. In this review, we have discussed the recent In Vivo studies demonstrating the role of various genetic factors in regulating dynamics of different ASCs viz.
    [Show full text]
  • Stem Cell Therapy and Gene Transfer for Regeneration
    Gene Therapy (2000) 7, 451–457 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt MILLENNIUM REVIEW Stem cell therapy and gene transfer for regeneration T Asahara, C Kalka and JM Isner Cardiovascular Research and Medicine, St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, USA The committed stem and progenitor cells have been recently In this review, we discuss the promising gene therapy appli- isolated from various adult tissues, including hematopoietic cation of adult stem and progenitor cells in terms of mod- stem cell, neural stem cell, mesenchymal stem cell and ifying stem cell potency, altering organ property, accelerating endothelial progenitor cell. These adult stem cells have sev- regeneration and forming expressional organization. Gene eral advantages as compared with embryonic stem cells as Therapy (2000) 7, 451–457. their practical therapeutic application for tissue regeneration. Keywords: stem cell; gene therapy; regeneration; progenitor cell; differentiation Introduction poietic stem cells to blood cells. The determined stem cells differentiate into ‘committed progenitor cells’, which The availability of embryonic stem (ES) cell lines in mam- retain a limited capacity to replicate and phenotypic fate. malian species has greatly advanced the field of biologi- In the past decade, researchers have defined such com- cal research by enhancing our ability to manipulate the mitted stem or progenitor cells from various tissues, genome and by providing model systems to examine including bone marrow, peripheral blood, brain, liver cellular differentiation. ES cells, which are derived from and reproductive organs, in both adult animals and the inner mass of blastocysts or primordial germ cells, humans (Figure 1).
    [Show full text]
  • Progenitor Cell Therapy for the Treatment of Damaged Myocardium
    Progenitor Cell Therapy for the Treatment of Damaged Protocol Myocardium due to Ischemia (20218) Medical Benefit Effective Date: 01/01/11 Next Review Date: 07/22 Preauthorization No Review Dates: 09/10, 07/11, 07/12, 07/13, 07/14, 07/15, 07/16, 07/17, 07/18, 07/19, 07/20, 07/21 This protocol considers this test or procedure investigational. If the physician feels this service is medically necessary, preauthorization is recommended. The following protocol contains medical necessity criteria that apply for this service. The criteria are also applicable to services provided in the local Medicare Advantage operating area for those members, unless separate Medicare Advantage criteria are indicated. If the criteria are not met, reimbursement will be denied and the patient cannot be billed. Please note that payment for covered services is subject to eligibility and the limitations noted in the patient’s contract at the time the services are rendered. RELATED PROTOCOLS Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used With Autologous Bone Marrow) Stem Cell Therapy for Peripheral Arterial Disease Populations Interventions Comparators Outcomes Individuals: Interventions of interest Comparators of interest Relevant outcomes include: • With acute cardiac are: are: • Disease-specific survival ischemia • Progenitor cell therapy • Standard therapy • Morbid events • Functional outcomes • Quality of life • Hospitalizations Individuals: Interventions of interest Comparators of interest Relevant outcomes
    [Show full text]
  • Differential Contributions of Haematopoietic Stem Cells to Foetal and Adult Haematopoiesis: Insights from Functional Analysis of Transcriptional Regulators
    Oncogene (2007) 26, 6750–6765 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW Differential contributions of haematopoietic stem cells to foetal and adult haematopoiesis: insights from functional analysis of transcriptional regulators C Pina and T Enver MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK An increasing number of molecules have been identified ment and appropriate differentiation down the various as candidate regulators of stem cell fates through their lineages. involvement in leukaemia or via post-genomic gene dis- In the adult organism, HSC give rise to differentiated covery approaches.A full understanding of the function progeny following a series of relatively well-defined steps of these molecules requires (1) detailed knowledge of during the course of which cells lose proliferative the gene networks in which they participate and (2) an potential and multilineage differentiation capacity and appreciation of how these networks vary as cells progress progressively acquire characteristics of terminally differ- through the haematopoietic cell hierarchy.An additional entiated mature cells (reviewed in Kondo et al., 2003). layer of complexity is added by the occurrence of different As depicted in Figure 1, the more primitive cells in the haematopoietic cell hierarchies at different stages of haematopoietic differentiation hierarchy are long-term ontogeny.Beyond these issues of cell context dependence, repopulating HSC (LT-HSC),
    [Show full text]
  • Corporate Medical Policy Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
    Corporate Medical Policy Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia File Name: progenitor_cell_therapy_for_the_treatment_of_damaged_myocardium_due_to_ischemia Origination: 11/2004 Last CAP Review: 10/2020 Next CAP Review: 10/2021 Last Review: 10/2020 Description of Procedure or Service Ischemia is the most common cause of cardiovascular disease and myocardial damage in the developed world. Despite impressive advances in treatment, ischemic heart disease is still associated with high morbidity and mortality. Current treatments for ischemic heart disease seek to revascularize occluded arteries, optimize pump function, and prevent future myocardial damage. However, current treatments are not able to reverse existing damage to heart muscle. Treatment with progenitor cells (i.e., stem cells) offers potential benefits beyond those of standard medical care, including the potential for repair and/or regeneration of damaged myocardium. The potential sources of embryonic and adult donor cells include skeletal myoblasts, bone marrow cells, circulating blood-derived progenitor cells, endometrial mesenchymal stem cells (MSCs), adult testis pluripotent stem cells, mesothelial cells, adipose-derived stromal cells, embryonic cells, induced pluripotent stem cells, and bone marrow MSCs, all of which are able to differentiate into cardiomyocytes and vascular endothelial cells for regenerative medicine advanced therapy (RMAT). The RMAT designation may be given if: (1) the drug is a regenerative medicine therapy (ie, a cell therapy), therapeutic tissue engineering product, human cell and tissue product, or any combination product; (2) the drug is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and (3) preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs.
    [Show full text]
  • Human Haemopoietic Progenitor Cell Mobilization
    Human Haemopoietic Progenitor Cell Mobilization Michael John Watts A thesis submitted to the University of London for the degree of Doctor of Philosophy 1999 The Department of Haematology University College London Medical School University College London 98, Chenies Mews LONDON WC1E6HX ProQuest Number: U642271 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U642271 Published by ProQuest LLC(2015). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract The advent of recombinant growth factors in the late 1980's has ushered in a new era of haematopoietic progenitor cell (HPC) therapy by facilitating the mobilization of bone marrow progenitors into the circulation where they can be collected in large numbers by apheresis. The work of this thesis has defined the minimal and optimal CD34+ cell threshold requirements for engraftment. The frequency of poor mobilization was noted and risk factors determined. It was demonstrated that poor mobilization was usually a feature of bone marrow damage rather than a specific mobilization defect. In addition, studies in normal volunteers indicated that there was wide inter-individual variation in G-CSF induced progenitor cell mobilization which was not due to G-CSF pharmacodynamic variability.
    [Show full text]
  • Cell Cycle Inhibitors in Normal and Tumor Stem Cells
    Oncogene (2004) 23, 7256–7266 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $30.00 www.nature.com/onc Cell cycle inhibitors in normal and tumor stem cells Tao Cheng*,1 1Department of Radiation Oncology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA Emerging data suggest that stem cells may be one of the cell types have been or are being defined, the hemato- key elements in normal tissue regeneration and cancer poietic stem cell (HSC) remains one of the best-studied development, although they are not necessarily the same stem cell types and therefore data have been largely entity in both scenarios. As extensively demonstrated in obtained from HSCs partially in comparison with the the hematopoietic system, stem cell repopulation is other stem cell types such as the neural stem cell (NSC). hierarchically organized and is intrinsically limited by The distinct impacts of different CKIs in stem cell the intracellular cell cycle inhibitors. Their inhibitory populations underscore the crucial role that cell cycle effects appear to be highly associated with the differentia- inhibitors play in stem cell regulation and offer new tion stage in stem/progenitor pools. While this negative insights into the mechanisms of cancer development, regulation is important for maintaining homeostasis, especially in light of the concept of ‘tumor stem cell’ especially at the stem cell level under physiological cues (TSC) (or described as ‘cancer stem cell’ in general or or pathological insults, it constrains the therapeutic use of ‘leukemic stem cells’ in leukemias by some other adult stem cells in vitro and restricts endogenous tissue investigators in the field).
    [Show full text]
  • Regulation of Stem/Progenitor Cell Maintenance by BMP5 in Prostate
    RESEARCH ARTICLE Regulation of stem/progenitor cell maintenance by BMP5 in prostate homeostasis and cancer initiation Mathieu Tremblay, Sophie Viala†, Maxwell ER Shafer†, Adda-Lee Graham-Paquin, Chloe Liu, Maxime Bouchard* Goodman Cancer Research Centre and Department of Biochemistry, McGill University, Montreal, Canada Abstract Tissue homeostasis relies on the fine regulation between stem and progenitor cell maintenance and lineage commitment. In the adult prostate, stem cells have been identified in both basal and luminal cell compartments. However, basal stem/progenitor cell homeostasis is still poorly understood. We show that basal stem/progenitor cell maintenance is regulated by a balance between BMP5 self-renewal signal and GATA3 dampening activity. Deleting Gata3 enhances adult prostate stem/progenitor cells self-renewal capacity in both organoid and allograft assays. This phenotype results from a local increase in BMP5 activity in basal cells as shown by the impaired self-renewal capacity of Bmp5-deficient stem/progenitor cells. Strikingly, Bmp5 gene inactivation or BMP signaling inhibition with a small molecule inhibitor are also sufficient to delay prostate and skin cancer initiation of Pten-deficient mice. Together, these results establish BMP5 as a key regulator of basal prostate stem cell homeostasis and identifies a potential therapeutic approach against Pten-deficient cancers. *For correspondence: [email protected] † Introduction These authors contributed equally to this work Maintaining homeostasis in adult tissues requires a fine balance between stem cell maintenance and differentiation (Morrison and Kimble, 2006). An amplification of the stem/progenitor cell pool at Competing interests: The the expense of cell differentiation or, conversely, the depletion of the stem/progenitor cell pool by authors declare that no premature differentiation are both expected to be detrimental to tissue homeostasis (Signer and competing interests exist.
    [Show full text]
  • Application of the in Vitro Hoxb8 Model System to Characterize the Contributions of Neutrophil–LPS Interaction to Periodontal Disease
    pathogens Article Application of the In Vitro HoxB8 Model System to Characterize the Contributions of Neutrophil–LPS Interaction to Periodontal Disease Maja Sochalska 1,* , Magdalena B. Sta ´nczyk 1, Maria U˙zarowska 1, Natalia Zubrzycka 1, Susanne Kirschnek 2 , Aleksander M. Grabiec 1 , Tomasz Kantyka 3,4 and Jan Potempa 1,5 1 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] (M.B.S.); [email protected] (M.U.); [email protected] (N.Z.); [email protected] (A.M.G.); [email protected] (J.P.) 2 Institute of Medical Microbiology and Hygiene, Medical Center–University of Freiburg, Faculty of Medicine, 79104 Freiburg, Germany; [email protected] 3 Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] 4 Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway 5 Department of Oral Immunity and Infectious Diseases, University of Louisville, School of Dentistry, Louisville, KY 40202, USA * Correspondence: [email protected] Received: 5 June 2020; Accepted: 29 June 2020; Published: 1 July 2020 Abstract: (1) Background: Studying neutrophils in vitro is difficult since these cells are terminally differentiated and are easily activated during isolation. At the same time, most of the available model cell lines are associated with certain limitations, such as functional deficiency or a lack of expression of surface markers characteristic of neutrophils. P. gingivalis is a periodontopathogen that causes dysbiosis in subgingival bacterial biofilm. This triggers the accumulation of functional neutrophils in the periodontium.
    [Show full text]
  • Ezh2, the Histone Methyltransferase of PRC2, Regulates the Balance Between Self-Renewal and Differentiation in the Cerebral Cortex
    Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex João D. Pereiraa, Stephen N. Sansoma, James Smitha, Marc-Werner Dobeneckerb, Alexander Tarakhovskyb, and Frederick J. Liveseya,1 aGurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, United Kingdom; and bLaboratory of Lymphocyte Signaling, The Rockefeller University, New York, NY 10021 Edited by Gerald R. Crabtree, Howard Hughes Medical Institute, Stanford, CA, and approved August 4, 2010 (received for review February 26, 2010) Multipotent progenitor cells of the cerebral cortex balance self- Knockout of the Bmi1 subunit of PRC1 has little effect on renewal and differentiation to produce complex neural lineages in progenitor cell self-renewal during development but is essential for a fixed temporal order in a cell-autonomous manner. We studied neural stem cell maintenance in the adult CNS (19). However, the role of the polycomb epigenetic system, a chromatin-based acute deletion of Bmi1 by RNAi does compromise cortical pro- repressive mechanism, in controlling cortical progenitor cell self- genitor cell self-renewal (20). Furthermore, removal of Ring1B, an renewal and differentiation. We found that the histone methyl- ubiquitin ligase component of PRC1, from the developing cortex transferase of polycomb repressive complex 2 (PCR2), enhancer of during neurogenesis lengthens the period of neurogenesis and Zeste homolog 2 (Ezh2), is essential for controlling the rate at
    [Show full text]
  • Cyclin D2 Is Critical for Intermediate Progenitor Cell Proliferation in the Embryonic Cortex
    9614 • The Journal of Neuroscience, July 29, 2009 • 29(30):9614–9624 Development/Plasticity/Repair Cyclin D2 Is Critical for Intermediate Progenitor Cell Proliferation in the Embryonic Cortex Sara B. Glickstein,1 Julie A. Monaghan,2 Hajira B. Koeller,1,2 Tiffanie K. Jones,3 and M. Elizabeth Ross1,2 1Department of Neurology and Neuroscience and 2Graduate Program in Neuroscience, Weill Medical College of Cornell University, New York, New York 10021, and 3Yale University, School of Medicine, New Haven, Connecticut 06510 Expression of cyclins D1 (cD1) and D2 (cD2) in ventricular zone and subventricular zone (SVZ), respectively, suggests that a switch to cD2 could be a requisite step in the generation of cortical intermediate progenitor cells (IPCs). However, direct evidence is lacking. Here, cD1 or cD2 was seen to colabel subsets of Pax6-expressing radial glial cells (RGCs), whereas only cD2 colabeled with Tbr2. Loss of IPCs in cD2Ϫ/Ϫ embryonic cortex and analysis of expression patterns in mutant embryos lacking cD2 or Tbr2 indicate that cD2 is used as progenitors transition from RGCs to IPCs and is important for the expansion of the IPC pool. This was further supported by the laminar thinning, microcephaly, and selective reduction in the cortical SVZ population in the cD2Ϫ/Ϫcortex. Cell cycle dynamics between embry- onic day 14–16 in knock-out lines showed preserved parameters in cD1 mutants that induced cD2 expression, but absence of cD2 was not compensated by cD1. Loss of cD2 was associated with reduced proliferation and enhanced cell cycle exit in embryonic cortical progenitors, indicating a crucial role of cD2 for the support of cortical IPC divisions.
    [Show full text]
  • Age-Related Inflammation Triggers Skeletal Stem/Progenitor Cell Dysfunction
    Age-related inflammation triggers skeletal stem/ progenitor cell dysfunction Anne Marie Josephsona,b, Vivian Bradaschia-Correaa, Sooyeon Leea, Kevin Leclerca, Karan S. Patela, Emma Muinos Lopeza, Hannah P. Litwaa, Shane S. Neibarta, Manasa Kadiyalaa, Madeleine Z. Wonga, Matthew M. Mizrahia, Nury L. Yima, Austin J. Rammea, Kenneth A. Egola, and Philipp Leuchta,b,1 aDepartment of Orthopedic Surgery, New York University School of Medicine, New York, NY 10003; and bDepartment of Cell Biology, New York University School of Medicine, New York, NY 10016 Edited by Helen M. Blau, Stanford University, Stanford, CA, and approved February 25, 2019 (received for review June 21, 2018) Aging is associated with impaired tissue regeneration. Stem cell Results number and function have been identified as potential culprits. We Skeletal Stem Cell Frequency Decreases with Aging. To investigate a first demonstrate a direct correlation between stem cell number and clinically relevant age-associated effect on skeletal stem cell fre- time to bone fracture union in a human patient cohort. We then quency and function, we first examined iliac crest bone graft devised an animal model recapitulating this age-associated decline in (ICBG) samples from 36 patients (20 male, 16 female) with ages bone healing and identified increased cellular senescence caused by a ranging from 24 to 89 y who underwent operative fixation of an systemic and local proinflammatory environment as the major contrib- upper- or lower-extremity fracture. FACS with CD271 as a human utor to the decline in skeletal stem/progenitor cell (SSPC) number and skeletal stem cell marker (8–11) revealed that SSPC frequency function.
    [Show full text]